✦ LIBER ✦

The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline

✍ Scribed by Leitch, Heather A.; Buckstein, Rena; Shamy, April; Storring, John M.

Book ID: 123179242
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 333 KB
Volume: 85
Category: Article
ISSN: 1040-8428
DOI: 10.1016/j.critrevonc.2012.07.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of myelodysplastic syndromes w

Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide

✍ C. Kelaidi; S. Park; S. Brechignac; L. Mannone; N. Vey; H. Dombret; L. Aljassem; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 98 KB

SIE, SIES, GITMO evidence-based guidelin

SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma

✍ Giovanni Barosi; Giampaolo Merlini; Atto Billio; Mario Boccadoro; Paolo Corradin 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 223 KB

Combination of 5-azacytidine and thalido

Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia

✍ Azra Raza; Murtaza Mehdi; Muhammad Mumtaz; Fahad Ali; Steven Lascher; Naomi Gali 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

## Abstract ## BACKGROUND. The treatment of myelodysplastic syndromes (MDS) remains a challenge to the clinician despite recent advances. Many patients will either not respond or will have only limited and/or brief responses to single‐agent therapy. Eventually, 30% of patients with MDS will progre

Clinical practice guideline for the diag

Clinical practice guideline for the diagnosis and treatment of pituitary apoplexy

✍ Vicente, Almudena; Lecumberri, Beatriz; Gálvez, María Ángeles 📂 Article 📅 2013 🏛 Elsevier ⚖ 761 KB

Nutrition in clinical practice—the refee

Nutrition in clinical practice—the refeeding syndrome: illustrative cases and guidelines for prevention and treatment

✍ Stanga, Z; Brunner, A; Leuenberger, M; Grimble, R F; Shenkin, A; Allison, S P; L 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB

Recombinant human erythropoietin for the

Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: A clinical and erythrokinetic assessment

✍ G. E. G. Verhoef; P. Zachée; A. Ferrant; H. Demuynck; D. Selleslag; L. Van Hove; 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 705 KB